-
Beyond the Congress Video Edits Susan O'Brien_recap_#BeyondASH21recap
3:44
-
Beyond the Congress Video Edits Nina Shah_recap_#BeyondASH21recap
4:20
-
Beyond the Congress Video Edits Kenneth Anderson_recap_#BeyondASH21recap
2:48
-
Beyond the Congress Video Edits Courtney DiNardo_recap_#BeyondASH21recap
4:12
-
Beyond the Congress Video Edits Sagar Lonial_recap_#BeyondASH21recap
5:33
-
Beyond the Congress Video Edits Brad Kahl_recap_#BeyondASH21recap
7:42
-
Beyond the Congress Video Edits John Leonard_recap_#BeyondASH21recap
5:15
-
Beyond the Congress Video Edits Sonali Smith_recap_#BeyondASH21recap
2:41
-
Beyond the Congress Video Edits Nitin Jain_recap_#BeyondASH21recap
3:07
-
Constantine Si Lun Tam, MBBS, MD Peter MacCallum Cancer Centre University of Melbourne 5Live #ASCO20
1:43
Key Insights on Three-year follow-up of treatment-naïve and previously treated patients with Waldenström macroglobulinemia (WM) receiving single-agent zanubrutinib
-
Constantine Si Lun Tam, MBBS, MD Peter MacCallum Cancer Centre University of Melbourne 5Live #ASCO20
5:54
"Key Insights on ASPEN: Results of a phase III randomized trial of zanubrutinib versus ibrutinib for patients with Waldenström macroglobulinemia (WM) "
ABOUT
Bio Ascend is an independent medical education company committed to supporting healthcare providers in their efforts to translate innovative science into clinical practice.
The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components, as well as extensive experience in planning, executing, and assessing meaningful education for clinicians.
CONNECT
© Copyright 2021 Bio Ascend, a Vaniam Group company